GlassScriptPhysician profile
Jessica E Hong
NPI 1629616453
$24,665.03
in general payments reported to CMS, 2019-2025
58 companies · $4,897 in 2025
The $4,897 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,805 · 2022: $3,490 · 2023: $4,589 · 2024: $5,884 · 2025: $4,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $55.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,314.80 |
| Education | $55.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,985.60 | 2021-2025 | |
| Ucb, INC. | $2,527.61 | 2021-2025 | Nayzilam, Fintepla, Briviact |
| Livanova USA, INC. | $2,225.90 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $1,485.05 | 2021-2023 | Aimovig |
| Lundbeck LLC | $1,332.46 | 2021-2025 | Vyepti |
| Mdd US Operations, LLC | $1,224.17 | 2021-2025 | Gocovri, Apokyn, Gocovri |
| Pfizer INC. | $958.31 | 2022-2025 | |
| Lilly USA, LLC | $917.37 | 2021-2025 | Emgality, Reyvow, Amyvid |
| Teva Pharmaceuticals USA, INC. | $879.70 | 2021-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Tonix Medicines, INC. | $777.29 | 2024-2025 | Zembrace Symtouch |
| Sk Life Science, INC. | $734.92 | 2021-2025 | Xcopri |
| Jazz Pharmaceuticals INC. | $701.54 | 2021-2025 | |
| Neurelis, INC. | $685.10 | 2021-2025 | Valtoco |
| Avanir Pharmaceuticals, INC. | $605.46 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $553.48 | 2021-2024 | Onzetra Xsail, Contrave |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.